RG
IMMU

Redmile Group’s Immunomedics Inc IMMU Stock Holding History

Redmile Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,234,934
Closed -$275M – 97
2020
Q3 		$275M Sell
3,234,934
-254,966
-7% -$12.9M 5.05% 3
2020
Q2 		$124M Buy
+3,489,900
New +$102M 2.28% 12
2017
Q2 		– Sell
-3,380,846
Closed -$21.9M – 70
2017
Q1 		$21.9M Buy
+3,380,846
New +$17.1M 1.42% 27

Redmile Group's IMMU Position: Q4 2020 in Review

Redmile Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 3,234,934 shares — an estimated $275M sold.

Redmile Group first reported a position in IMMU in Q1 2017 and held it in 3 quarters. The position peaked at $275M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Redmile Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Redmile Group sold 3,234,934 Immunomedics Inc shares in Q4 2020, an estimated $275M.
  • Redmile Group first reported a position in Immunomedics Inc in Q1 2017 and held it in 3 quarters.
  • Redmile Group's Immunomedics Inc position peaked at $275M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Redmile Group's 13F filing for Q4 2020, filed 16 Feb 2021.